Showing results (91-100 of 112) with videos related to
Sort By:
Pageof 12
JAMA Oncology|August 14, 2020
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical TrialKe-Da Yu, Fu-Gui Ye, Min He, et al.Frontiers in Oncology|April 24, 2025
Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical practiceStefania Gori, Alessandra Fabi, Catia Angiolini, et al.Cancers|October 14, 2023
Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE StudyStefania Gori, Alessandra Fabi, Catia Angiolini, et al.Science China. Life Sciences|May 17, 2022
A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancerChang Gong, Ziliang Cheng, Yaping Yang, et al.NPJ Breast Cancer|July 17, 2024
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY studySimone Scagnoli, Simona Pisegna, Angela Toss, et al.Breast (Edinburgh, Scotland)|April 28, 2026
Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 studyFrancesca Ligorio, Leonardo Provenzano, Giuseppe Fotia, et al.Breast (Edinburgh, Scotland)|January 31, 2026
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2Giacomo Mazzoli, Leonardo Provenzano, Maria Vittoria Dieci, et al.NPJ Breast Cancer|February 13, 2021
Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variantsMatteo Lambertini, Marcello Ceppi, Anne-Sophie Hamy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2025
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA StatusMatteo Lambertini, Eva Blondeaux, Loredana M Tomasello, et al.Cancer|May 16, 2024
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort studyFrancesco Schettini, Eva Blondeaux, Chiara Molinelli, et al.Pageof 12